Clinical Trial Update: Urolithin A Supplementation in Middle-aged Adults With Obesity [NA]

View source ↗

Summary

A completed clinical trial evaluated urolithin A supplementation in middle-aged adults with obesity, with indications including vascular dementia and cognitive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Obesity
• Vascular Dementia

Drugs mentioned

• Urolithin A (Urolithin A)

Snippet

Sponsor: University of Oklahoma | Conditions: Obesity, Vascular Dementia | NA | Status: COMPLETED